Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Barts Health NHS Trust

Skip to Main Content

Feasibility of the Latella Implant System for Medial Osteoarthritis (OA)


Open to: All Genders

Age: 30 Years - 65 Years

Medical Conditions


The objective of this study is to evaluate the safety and technical feasibility of implanting the Latella Implant System in the treatment of patients with medial osteoarthritis of the knee.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Nov 2013

Sep 2015


Intervention Type : Device
Intervention Name : Latella Knee Implant System
Intervention Arm Group : Latella Knee Implant System

You can take part if:

Inclusion Criteria: - History of pain as due to medial osteoarthritis Exclusion Criteria: - Rheumatoid arthritis - Joint or ligament instability - Metal ion allergy

You may not be able to take part if:

This is in the inclusion criteria above

Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Barts Health NHS Trust

The study is sponsored by Cotera, Inc. .

We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.

Is this study information helpful?

What will you do next?

Read full details

for Trial ID: NCT02002637

Last updated

This page is to help you find out about a research study and if you may be able to take part

The information is provided by researchers and we rely on them to keep it up-to-date. You can see more information by clicking on the 'Read full details' link above.

To take part, please print or share the study information with your GP/healthcare provider or contact the research team directly.